大型制药公司投资了 MAGA 政策规划，目标是废除拜登的医疗保险药品价格谈判计划。 Big Pharma invested in MAGA policy planning, targeting the repeal of Biden's Medicare drug price negotiation program.
大型制药公司在为潜在的新特朗普政府规划 MAGA 政策议程的组织中投入了大量资金，特别关注一项将废除拜登政府允许医疗保险通过谈判降低药品价格的计划的政策。 Big Pharma has invested heavily in organizations planning the MAGA policy agenda for a potential new Trump administration, specifically focusing on a policy that would repeal the Biden administration's program allowing Medicare to negotiate lower drug prices. 制药行业对极右翼的“2025计划”做出了重大贡献，该议程旨在为特朗普总统任期内的早期行动提供方向。 The pharmaceutical industry has contributed significantly to the far-right Project 2025, an agenda meant to serve as direction for early actions in a Trump presidency. 国会禁止医疗保险参与处方药价格谈判（这是美国药品价格高于其他国家的主要原因），民主党于 2022 年颁布立法，制定价格谈判试点计划。 In response to Congress barring Medicare from negotiating prescription drug prices, which is a primary reason for higher drug prices in the U.S. compared to other countries, Democrats enacted legislation in 2022 to create a price negotiation pilot program.